Document is current

Any future updates will be listed below

Correction to: Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma: final update of the pivotal ERIVANCE BCC study

Crossref DOI link: https://doi.org/10.1186/s12885-019-5568-6

Published Online: 2019-04-18

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark